BASSI, NICOLA
 Distribuzione geografica
Continente #
NA - Nord America 4.483
AS - Asia 1.408
EU - Europa 1.036
AF - Africa 289
SA - Sud America 244
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 17
Totale 7.507
Nazione #
US - Stati Uniti d'America 4.338
SG - Singapore 455
CN - Cina 381
HK - Hong Kong 246
DE - Germania 191
BR - Brasile 162
FI - Finlandia 133
IT - Italia 112
PL - Polonia 69
GB - Regno Unito 67
SE - Svezia 66
UA - Ucraina 61
VN - Vietnam 48
FR - Francia 47
RU - Federazione Russa 44
NL - Olanda 40
TR - Turchia 19
CA - Canada 16
AR - Argentina 15
IQ - Iraq 15
MX - Messico 15
AT - Austria 14
LY - Libia 14
UZ - Uzbekistan 14
ES - Italia 13
NP - Nepal 13
ZA - Sudafrica 13
CM - Camerun 12
NZ - Nuova Zelanda 12
PE - Perù 12
PK - Pakistan 12
PS - Palestinian Territory 12
RS - Serbia 12
DJ - Gibuti 11
DO - Repubblica Dominicana 11
ID - Indonesia 11
JP - Giappone 11
KH - Cambogia 11
MU - Mauritius 11
NE - Niger 11
AZ - Azerbaigian 10
ET - Etiopia 10
GT - Guatemala 10
IE - Irlanda 10
NG - Nigeria 10
PY - Paraguay 10
SK - Slovacchia (Repubblica Slovacca) 10
TZ - Tanzania 10
YE - Yemen 10
BF - Burkina Faso 9
IS - Islanda 9
LC - Santa Lucia 9
MN - Mongolia 9
MY - Malesia 9
NI - Nicaragua 9
NO - Norvegia 9
TW - Taiwan 9
BG - Bulgaria 8
CH - Svizzera 8
CO - Colombia 8
CW - ???statistics.table.value.countryCode.CW??? 8
CZ - Repubblica Ceca 8
EC - Ecuador 8
EG - Egitto 8
GR - Grecia 8
HT - Haiti 8
IL - Israele 8
IN - India 8
KE - Kenya 8
LB - Libano 8
PT - Portogallo 8
RW - Ruanda 8
SD - Sudan 8
AM - Armenia 7
BA - Bosnia-Erzegovina 7
CU - Cuba 7
DK - Danimarca 7
DZ - Algeria 7
GA - Gabon 7
GF - Guiana Francese 7
GM - Gambi 7
HN - Honduras 7
KZ - Kazakistan 7
LV - Lettonia 7
MA - Marocco 7
ME - Montenegro 7
MR - Mauritania 7
SN - Senegal 7
TH - Thailandia 7
TN - Tunisia 7
YT - Mayotte 7
ZW - Zimbabwe 7
AF - Afghanistan, Repubblica islamica di 6
AO - Angola 6
BD - Bangladesh 6
BE - Belgio 6
BJ - Benin 6
BO - Bolivia 6
BW - Botswana 6
BY - Bielorussia 6
Totale 7.241
Città #
Fairfield 578
Woodbridge 484
Chandler 344
Ann Arbor 332
Ashburn 295
Singapore 272
Houston 269
Jacksonville 255
Hong Kong 241
Seattle 231
Cambridge 225
Wilmington 222
Boardman 106
Beijing 100
Princeton 97
Santa Clara 67
Bytom 62
Medford 61
Nanjing 61
Des Moines 54
San Diego 44
Roxbury 42
Helsinki 41
Munich 36
Nanchang 23
Dearborn 21
Shenyang 16
Ho Chi Minh City 15
Los Angeles 15
Padova 15
Hebei 13
Jiaxing 13
Tashkent 13
Guangzhou 12
New York 12
Tripoli 12
Djibouti 11
Hefei 11
Jinan 11
Redwood City 11
São Paulo 11
Niamey 10
Norwalk 10
Phnom Penh 10
Baku 9
Castries 9
Changsha 9
Dar es Salaam 9
Nuremberg 9
Rio de Janeiro 9
Ulan Bator 9
Vienna 9
Belgrade 8
Boston 8
Buffalo 8
Dong Ket 8
Hanoi 8
Kigali 8
Lima 8
Managua 8
Milan 8
Cairo 7
Dakar 7
Dublin 7
Falls Church 7
Harare 7
Johannesburg 7
Lahore 7
Nairobi 7
Phoenix 7
Reykjavik 7
Rome 7
Sanaa 7
Stockholm 7
Turku 7
Willemstad 7
Addis Ababa 6
Amman 6
Athens 6
Auckland 6
Bishkek 6
Cagliari 6
Cotonou 6
Dallas 6
Falkenstein 6
Guatemala City 6
Havana 6
Lagos 6
Lusaka 6
Montevideo 6
Najaf 6
Nouakchott 6
Noumea 6
Ouagadougou 6
Riga 6
San Pedro Sula 6
Santo Domingo 6
Toronto 6
Verona 6
Abidjan 5
Totale 5.176
Nome #
Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease. 197
Anti-SAE antibodies in autoimmune myositis: Identification by unlabelled protein immunoprecipitation in an Italian patient cohort. 197
Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study 195
PTX3, Anti-PTX3, and Anti-C1q Autoantibodies in Lupus Glomerulonephritis. 180
In vivo delivery of naked antisense oligos in aged mdx mice analysis of dystrophin restoration in skeletal and cardiac muscle 177
17-β-estradiol affects BLyS serum levels and the nephritogenic autoantibody network accelerating glomerulonephritis in NZB/WF1 mice. 176
Antigen preparation for immunological studies in systemic autoimmune diseases. 175
Antigen preparation for immunological studies in systemic autoimmune diseases 166
Autoinflammation and autoimmunity: Bridging the divide. 159
Immunization with pentraxin 3 (PTX3) leads to anti-PTX3 antibody production and delayed lupus-like nephritis in NZB/NZW F1 mice. 154
The olfactory function is impaired in patients with idiopathic inflammatory myopathies. 150
Infections and autoimmunity: the multifaceted relationship. 149
OxLDL/β2GPI-anti-oxLDL/β2GPI complex and atherosclerosis in SLE patients. 141
Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay 141
Emerging and critical issues in the pathogenesis of lupus. 138
Serological markers in psoriatic arthritis: promising tools 137
Commercial blot assays in the diagnosis of systemic rheumatic diseases 133
SLE diagnosis and treatment: When early is early 132
Biological and clinical relevance of anti-prothrombin antibodies. 131
Polymyositis, dermatomyositis and malignancy: a further intriguing link 123
Autoantibodies in polymyositis and dermatomyositis. 116
Autoantibodies toward pathogenic and protective molecules in systemic lupus erythematosus: anti-oxLDL/ß2GPI and anti-PTX3 antibodies. 114
Infection as triggers and complication of sistemic lupus erythematosus 110
Systemic delivery of therapeutic nucleic acids into skeletal muscle by means of lipid-based vectors 109
Autoantibody testing in patients with myositis: clinical accuracy of a multi parametric line immunoassay 108
Anti-PTX3 antibody: a new antibody in lupus. 107
Induction of the 'ASIA' syndrome in NZB/NZWF1 mice after injection of complete Freund's adjuvant (CFA) 107
Vaccination of mice for research purpose: alum is as effective as and safer than complete Freund adjuvant. 106
IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus 104
Autoantibodies, polymorphisms in the serotonin pathway, and human leukocyte antigen class II alleles in chronic fatigue syndrome 103
DILAYED SYSTEMIC LUPUS ERYTHEMATOSUS SYMPTOMS AND INCREASED SURVIVAL BY SERPINB3 IN LUPUS-PRONE MICE 101
Serpins, Immunity and Autoimmunity: Old Molecules, New Functions. 100
null 99
oxLDL/beta 2GPI complex and anti-oxLDL/beta 2GPI in SLE: Prevalence and correlates 95
Galectin-3 in autoimmunity and autoimmune diseases 93
Pentraxins, anti-pentraxins antibodies and atherosclerosis 93
Studio pilota sull’efficacia di una formulazione micellare contenente un complesso di Au(III) nel trattamento dell’artrite sperimentale da collagene nel topo 92
Aspetti clinici e immunologici associati agli anitcorpi antisintetasi in una casistica di 42 pazienti 90
Anti-MI2 antibody detection in myositis sera by chemiluminescent or chromogenic western blot assay. 86
Miopatia Subclinica in pazienti affetti da neoplasia del colon-retto: ipotesi sulla patogenesi delle miositi paraneoplastiche 84
NZB/WF1 MICE DEVELOPED ASIA SYNDROME WHEN INJECTED WITH COMPLETE FREUND'S ADJUVANT 83
Expression of regeneration markers in muscle biopsies from patients affected with autoimmune myositis. 82
IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus 81
The long pentraxin 3 and its role in autoimmunity 81
Is C-reactive protein an useful tool in monitoring SLE pregnant women? 80
Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study. 80
IgG anti-PTX3 nel lupus eritematoso sistemico 75
PENTRAXINA 3 (PTX3) E FIBROSI: STUDIO IMMUNOISTOCHIMICO SU BIOPSIE RENALI IN PAZIENTI CON LES. 73
The role of IgG, IgM, and IgA anti-DNA isotypes in systemic lupus erythematosus 72
Subclinical atherosclerosis in patients with psoriatic arthritis. 71
Predire e valutare la risposta clinica ad abatacept nei pazienti resistenti agli anti-TNF-alfa 71
Delay of nephritis in NZB/NZWF1 mice injected with pentraxin 3 70
Anti-PTX3: are they real? 70
Multicenter evaluation of a second-generation ELISA assay using the VCP-2 antigen for the detection of anti-citrullinated peptide antibodies 69
Serological testing in myositis patients: diagnostic accuracy of a commercial line blot assay. 68
Diagnosi precoce nel LES. 67
Il senso dell'olfatto nella poli-dermatomiosite. 67
Chronic fatigue syndrome: Characteristics and possible causes for its pathogenesis 66
PATHOGENETIC AND PROTECTIVE AUTOANTIBODIES INVOLVED IN LUPUS GLOMERULONEPHRITIS 65
Remissione clinica, terapia e danno cumulativo nel lupus eritematoso sistemico: risultati preliminari su una coorte di 100 pazienti 64
Prevention of glomerulonephritis in NZB/NZWF1 mice by immunization with pentraxin 3. 60
The sense of smell in polimyositis and dermatomyositis. 60
OxLDL/beta2GPI-anti-oxLDL/beta2GPI complex and atherosclerosis in SLE patients. 59
Antiendothelial and antineuronal cells antibodies in patients with chronic fatigue syndrome. 59
Relationship between autoantibody profile and muscle histopathological findings in inflammatory myopathies 57
Modulation of glomerunephritis in NZB/WF1 mice: vaccination with PTX3 induces anti-PTX3 antibodies, delays the onset and decreases the severity of glomerulonephritis 57
Autoantibody detection in serum of patients with autoimmune myositis: identification of anti-SAE1/SAE2 antibodies by unlabelled protein imunoprecipitation. 54
Reduction of the olfactory function in patients with idiopathic inflammatory myopathies: a case control study. 54
Are anti-P antibodies associated with NPSLE? 54
Livelli sierici di BLyS (B lymphocyte stimulator) in pazienti non selezionati affetti da malattie reumatiche autoimmuni 51
Valutazione dell'accuratezza di un test line blot per la diagnosi sierologica di miosite autoimmune. 50
Immunization of NZB/NZWF1 mice with pentraxin 3 delays the onset and reduces the severity of glomerulonephritis. 50
Modello sperimentale di nefropatia lupica: ruolo della pentraxina 3 50
Prevalence of anti-annexine XI antibodies in patients with autoimmune rheumatic diseases. 45
Effect of SLE pregnancy on serum cytokines. 39
Immunization with PTX3 induces anti-PTX3 antibodies and delays proteinuria occurence and death in NZB/NZWF1 mice. 38
NZB/WF1 mice developed ASIA syndrome when injected with complete Freund's adjuvant. 36
Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay 35
Totale 7.531
Categoria #
all - tutte 23.530
article - articoli 19.615
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.145


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021575 0 0 16 69 23 51 27 84 82 90 74 59
2021/2022768 11 107 70 86 21 26 21 93 36 10 67 220
2022/2023686 159 76 7 70 119 89 3 59 67 2 23 12
2023/2024331 17 41 43 27 30 25 28 17 11 6 33 53
2024/20251.393 6 87 73 70 190 23 53 104 117 60 271 339
2025/20261.332 179 479 674 0 0 0 0 0 0 0 0 0
Totale 7.531